No Detail Found!

Role of heart rate reduction with ivabradine in left ventricular failure

Author(s)
Safia Batool Combined Military Hospital Jhelum/National University of Medical Sciences (NUMS), Pakistan
Jamal Waris Combined Military Hospital Jhelum/National University of Medical Sciences (NUMS), Pakistan
Muhammad Usman Sajid Combined Military Hospital Jhelum/National University of Medical Sciences (NUMS), Pakistan
Shazia Nisar Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Imran Khan Combined Military Hospital Peshawar/National University of Medical Sciences (NUMS) Pakistan
Hina Mushtaq Rehman Medical Institute, Peshawar Pakistan
Abstract
Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular failure patients. Study Design: Quasi experimental study. Place and Duration of Study: Study was conducted at Combined Military Hospital, Kharian, from Jul 2018 to Dec 2018. Methodology: Sixty four patients participated in the study. They were randomly divided into two groups of 32 each. One group was given Tab Ivabradine (10 mg twice a day) while second group received a placebo for a period of 4 weeks. After 4 weeks each patient was evaluated and heart rate, systolic and diastolic blood pressure were recorded. Mann-whitney U test selected to compare heart rate and ages of both groups t- test used to compare systolic and diastolic blood pressure among both groups. Chi-square test used to determine the association of heart rate between two groups. A p-value =0.05 was considered significant. Results: Median (IQR) heart rate was significantly lower in Ivabradine group 58.3 (4) as compared to placebo 64.1(1) (p<0.01). Systolic blood pressure (132.8 ± 3.6) was significantly lower in ivabradine group as compared to placebo group (137.1 ± 4.5) (p<0.01). Difference in diastolic blood pressure was insignificant in both groups (p= 0.55). There was a significant association between heart rate of 55-60 beats per minute and ivabradine use (p<0.01). Conclusion: Ivabradine is safe and efficative drug in reducing heart rate and systolic blood pressure for patients suffering from left ventricular failure. Early detection and management of left ventricular failure with ivabradine use leads to better prognosis of the disease.
Publication Details
Page(s) 1839-1842
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 70, Issue: 6, Year: 2020

Request the full text from PASTIC

Keywords
Heart rate, Left ventricular failure., Ivabradine
0

Citations

0

Downloads

49

Views